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Highlights: 
 
 Putative enzymes from gene databases are becoming accessible due to low 
cost of gene synthesis. 
 
 Cell-free protein expression allows the expression of identified putative 
genes. 
 
 Novel glucanase and xylanase assays are compatible with cell-free produced 
proteins. 
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 A streamlined pipeline integrating the steps described above has been 
established. 
 
 Putative glucanases and xylanases were characterised using this pipeline. 
 
Abstract: 
 
The rapid expansion in the number of sequenced genomes and metagenomes provides 
an exceptional resource for mining of the enzymes with biotechnologically relevant 
properties. However, the majority of protein production and analysis methods are not 
sufficiently cost-efficient and scalable to experimentally verify the results of 
computational genomic mining. Here, we present a pipeline based on Leishmania 
tarentolae cell-free system that was used to characterise 30 putative thermostable 
endo-1,4-β-glucanases and xylanases identified in public genomic databases. In order 
to analyse the recombinant proteins without purification, novel high-throughput 
assays for glucanase and xylanase activities were developed. The assays rely on 
solubilisation of labelled particulate substrates performed in multiwell plates. Using 
this approach both acidophilic and thermophilic enzymes were identified. The 
developed approach enables rapid discovery of new biotechnologically useful 
enzymes. 
 
Keywords: Cell-free, Glucanase, Xylanase, Enzyme, Discovery, Pipeline, 
Metagenomes 
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Introduction 
 
Lignocellulosic biomass is the most abundant renewable resource for sustainable 
production of food, fuels, chemicals, feed and fibre. Cellulose and xylan are the major 
polysaccharides of biomass, and endo-1,4-β-glucanases and xylanases are the 
enzymes that can degrade these polymers to sugar monomers for their use in nutrition 
or in industrial fermentation (Garvey et al., 2013; Park et al., 2015; Passos et al., 
2015). Natively produced by soil and ruminant microbes, these enzymes find use in 
paper and natural fibre processing, biofuel production, fodder processing, laundry 
detergents, and as additives to feed for ruminant livestock (Kuhad et al., 2011; Juturu 
and Wu, 2012). 
 
Naturally occurring enzymes frequently require adaptation for optimal use in 
manufacturing and industrial processes, where conditions differ from those found in 
nature. For example, a feed additive enzyme must have optimal activity at the pH and 
temperature of the animal digestive system, while being able to withstand the high 
temperatures of the feed pelleting process. Although advances in directed evolution 
approaches have greatly improved enzyme engineering, prospecting naturally 
occurring variants remains critical to effectively explore the vast solution space (Heux 
et al., 2015).  
 
Screening environmental samples for the desired enzymatic activity is generally 
cumbersome and inefficient. Xylanase or endo-1,4-β-glucanase activity of 
microorganisms can be identified colorimetrically by cultivating them on agar-plates 
with labelled substrate (Farrow and Arnold, 2011). However, only a fraction of 
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environmental microorganisms can be readily cultivated (Puspita et al., 2012; Vester 
et al., 2015) thus creating a strong bias in gene selection. Recent advances in 
metagenomic sequencing have dramatically increased the number of available gene 
candidates (Fernández-Arrojo et al., 2010). The abundance of potential candidate 
genes places greater emphasis on selection of most promising candidates. It is not yet 
possible to identify best lead candidates from thousands of potential candidates using 
bioinformatic analysis. However, it is possible to reduce the set of candidates while 
ensuring maximum diversity (Uchiyama and Miyazaki, 2009; Fernández-Arrojo et 
al., 2010). 
With decreasing cost of commercial de novo gene synthesis (Kosuri and Church, 
2014), synthesis of dozens to hundred of genes is easily achievable. The synthesised 
gene candidates are expressed and in some cases may be assayed directly in the lysate 
of the expression host (Mewis et al., 2011). In an alternative approach, genes may be 
expressed in vitro, thus bypassing cell cultivation and disruption steps. Cell-free 
protein expression reduces the time needed to obtain protein product considerably and 
is amenable to multiplexed operation. In the current study, we adapted the Leishmania 
tarentolae cell-free system (LTE) for this purpose. We chose the LTE system because 
it produces recombinant proteins of quality sufficient for their direct analysis without 
purification (Gagoski, Polinkovsky, et al., 2015).  
 
In order to realise the full potential of high throughput screening (HTS), we 
developed a novel continuous semi-quantitative assay for both xylanases and endo-
1,4-β-glucanases. The classical endpoint assay based on dinitrosalycilic acid (DNS) 
for reducing sugars (Miller, 1959) is time consuming and laborious even when 
streamlined methods of bacterial expression of proteins in 96-well plates and a 
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multiplexed DNS assay are implemented. The new assay is based on substrates (xylan 
and cellulose) labelled with a colorimetric dye that are stable at neutral and acidic 
conditions as well as at higher temperatures, facilitating characterization of enzyme 
activity at different temperatures and pH values. We demonstrate that the assays are 
suitable for analysis of recombinant proteins expressed in LTE. 
Materials and Methods 
Constructs 
The amino acid sequences of the catalytic domains of 15 xylanases and endo-1,4-β-
glucanases and the control xylanase (XynA) and endo-1,4-β-glucanase (EglS) were 
obtained from online databases (Table 1). The sequences were reverse translated and 
codon optimized with the Gene Designer 2.0 software (DNA 2.0) using the codon 
usage table for L. tarentolae (www.kazusa.or.jp/codon). The restriction sites for NcoI 
and NotI were omitted from the sequences by using synonymous codons. These two 
restriction sites were than introduced on the 3’ and 5’ end of the sequence, 
respectively. A stop codon was also introduced upstream of the NotI site. The 
optimized DNA sequences were synthesised by GeneScript and ProteinCT and cloned 
into the pLTE EGFP vector (Gagoski, Mureev, et al., 2015) using the NcoI and NotI 
restriction sites. The resulting plasmids were prepared using the NucleoBond® Xtra 
Midi / Maxi kit (Macherey-Nagel). In addition the control xylanase (xynA) and endo-
1,4-β-glucanase (eglS) genes were cloned into the pET21a vector using the NdeI and 
XhoI restriction sites.  
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Protein expression, purification and characterization  
The xylanase (xynA) and endo-1,4-β-glucanase (eglS) cloned into the pET21a vector 
were expressed in Escherichia coli and purified on a 1 mL HisTrap Crude column 
(GE Healthcare). The activity of the purified enzymes was determined by the DNS-
based colorimetric assay for reducing sugars (Miller, 1959) using birchwood-xylan 
(Sigma) and carboxymethyl cellulose (Sigma). The enzymes cloned in the pLTE 
EGFP vector, were expressed in the Leischmania tarentolae-based cell-free system 
(LTE). The LTE lysate and the feeding solution for cell-free expression were prepared 
and used as described previously (Johnston and Alexandrov, 2014). The final 
concentration of template DNA in the expression reaction was 10 nM. Test expression 
reactions were further supplemented with 1:200 v/v BODYPI-Lysine-tRNA 
(FluoroTect™ GreenLys, Promega) in order to fluorescently label the synthesis 
products. The reactions with the fluorescently labelled products were mixed 1:1 v/v 
4x NuPAGE sample buffer (Life Technologies) and denatured at 95 °C for 5 minutes 
before loading them on a NuPAGE Novex 4-12% Bis-Tris protein gel (Life 
Technologies, Australia). Gels were imaged for fluorescence in a ChemiDoc MP 
Systems (Bio-Rad, Australia) gel documentation system. The fluorescent bands on the 
gels were quantified with ImageJ, in order to obtain the relative expression levels. The 
LTE-expressed eGFP and a dilution series of purified eGFP of known concentration 
were also loaded on a separate gel as described above. This gel was then blotted onto 
an Osmonics NitroBind™ Nitrocellulose Transfer Membrane (GE LifeSciences) in 
Tris-Glycine transfer buffer using an XCell II™ Blot Module (Life Technologies). 
The membranes were blocked overnight with 1 x Casein Blocking Buffer (Sigma-
Aldrich) in 1 x PBS and 0.1% (v/v) Tween-20 (Sigma-Aldrich). The detection of the 
purified eGFP and the cell-free expressed eGFP was performed with a 1:2000 dilution 
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of GFP (D5.1) XP® Rabbit mAb (Cell Signaling) primary antibody and a 1:2500 
dilution of IRDye® 800CW Goat anti-Rabbit IgG (LI-COR) secondary antibody. 
Both antibodies were diluted in 1 x Casein Blocking Buffer (Sigma-Aldrich). The 
fluorescent secondary antibody was detected by scanning the blot with the Odyssey 
Infrared Imager (LI-COR) at 800 nm. The detected bands on the Western blot were 
quantified with ImageJ and the expression levels of eGFP in the LTE cell-free 
reaction was calculated using the the purified eGFP standards using GraphPad Prism 
6 software. This interpolated value was used to estimate the expression levels of the 
enzyme constructs by multiplying it with their relative expression levels recorded 
from the BODYPI-Lysine-tRNA co-expression.  
Enzymatic assay 
The enzymatic assays for the xylanases and endo-1,4-β-glucanases were performed 
with azurine-labeled (AZCL-) hydroxyethyl-cellulose and birchwood xylan 
(Megazyme). Both substrates were sieved through a 100 μm Falcon cell strainer (BD) 
before producing stock suspensions in water or 10 mM HEPES (pH 7.6). The 
substrate and corresponding enzyme (purified or in a cell-free reaction) were mixed 
and 10 mM HEPES (pH 7.6) was added up to 200 μL. Commercially available endo-
1,4-β-glucanase (ECONASE CEP) and xylanase (ECONASE HCP) resuspended in 
PBS as well as purified and cell-free produced EglS and XynA were used for the 
assay calibration experiments. For the novel enzyme screening the cell-free 
expression reactions containing the enzymes were first diluted 1:1 to 1:10 (v/v) in 
PBS, incubated at different temperatures for 1 minute. 20 μL of the heat-treated 
sample was then mixed with 20-40 μL of labelled substrate and the reactions were 
supplemented with phosphate-citrate buffer (pH: 7.2; 6.2; 5.15 or 4.1) to a total 
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volume of 200 μL. The increase of optical density at 590 nm (OD590) was measured 
with the Synergy 4 – BioTek plate reader (Millennium Science, Australia) with 10s-
long plate shaking intervals between reads. The plate reader temperature was set to 
40° C in order to simulate the body temperature of non-ruminant animas, and the 
xylanase reactions were measured for 90 minutes and the endo-1,4-β-glucanase 
reactions for 180 minutes.  The maximum slope of the read was evaluated with the 
Gen5 software (Bio-Tek) and further analyses of the data were performed with 
GraphPad Prism 6. The assay plates were incubated over night at room temperature 
after the kinetic read. If any of the reactions exhibited visibly higher absorption at 590 
nm that was previously not visible after the kinetic run, and this was the case for all 
triplicate reactions, then that reaction was marked with a red dot in the results. Assay 
plates, where there was increase of absorption at 590 nm in all of the wells were 
deemed as contaminated and were therefore repeated in order to verify the conditions 
at which the candidate shows low activity.     
 
Results and Discussion 
Continuous xylanase and endo-1,4-β-glucanase activity assay 
 
Characterization of specific xylanase and endo-1,4-β-glucanase activities first became 
possible with the establishment of the DNS-based assay for detecting reducing sugars 
(Miller, 1959). This is a laborious end point assay as it requires the sample to be 
incubated with the DNS-reagent at 100°C. In an alternative approach, labelled xylan 
and HE-cellulose are used for “on plate” discovery of microorganisms that secrete 
xylanase and endo-1,4-β-glucanase. Here enzymatic degradation of insoluble 
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substrate leads to formation of a clear halo around the secreting colony (Meddeb-
Mouelhi et al., 2014; Qu et al., 2015). 
We tested whether this principle can be utilised to build scalable multiplexed assays 
for xylanase and endo-1,4-β-glucanase activities. Increase in OD590 from the release 
of azurine dye (AZCL) was observed for both labelled substrates in a multi-well plate 
containing the mixture of the particulate, labelled xylan or HE-cellulose and the 
solution of the corresponding enzyme. However, the residual granular, insoluble 
substrate found on the bottom of the 96-well plate and the inhomogeneous diffusion 
of the solubilized oligosaccharides introduced large variations into the observed 
signal. Agitation of the plate between individual reads not only led to more uniform 
diffusion of the solubilized dye species, but also concentrated of the insoluble grains 
on the sides of the well, thus clearing the light path and reducing the noise. This 
mixing enabled a reliable recording of optical density over time (ΔOD590/Δt), which is 
essential for continuous, multiplexed and semi-quantitative analysis of xylanase and 
endo-1,4-β-glucanase activities.  
The dynamic range of the assay was determined by titrating substrates into the 
reaction mixture at a constant enzyme concentration (Figure 1A, 1B). While the 
heterogeneity of the substrates caused some variation between replicates, the mean 
values correlated well with the increase in substrate concentration. The endo-1,4-β-
glucanase assay demonstrated a robust linear response in the 200 to 700 μg/mL range 
of AZCL-cellulose with low background, while the xylanase assay linear range was 
between 200 and 450 μg/mL of AZCL-xylan. The enzyme activity in both assays for 
these substrate concentrations was recorded within the linear dynamic range of the 
plate-reader (OD 0.0-2.5). To further asses the robustness of the assay we incubated 
the labelled substrates at 100 °C and in phosphate-citrate buffer with ranging from pH 
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7.2 to 3.0. In both cases, there was no detectable increase in optical density of the 
soluble fraction. This observation demonstrates that the assay is suitable for semi-
quantitative characterisation of thermophilic and acidophilic enzymes. 
 
Adaptation of the developed assay to in vitro expressed enzymes 
 
The semi-quantitative enzymatic assay allowed us to assess the activity of the 
xylanases and endo-1,4-β-glucanases in high throughput mode, which shifted the rate-
limiting step to enzyme production. Therefore, we investigated whether in vitro 
translated enzymes could be analysed using the developed assays. We first confirmed 
that the LTE cell-free system itself does not generate a strong background signal in 
the assay (Figure S1). This was expected as the LTE cell-free system is based on the 
intracellular parasite of lizards L. tarentolae, which is unlikely to require activity of 
oligosaccharide degrading enzymes. Next we compared the activity of LTE spiked 
with recombinant endo-1,4-β-glucanase EglS and xylanase XynA and LTE expressing 
the same enzymes (Figure 1C, 1D). We concluded that 3-10 μL of enzyme-expressing 
crude cell-free reaction mixture contains sufficient amounts of enzyme to enable an 
assay response comparable to the one produced by a purified enzyme. The activity of 
3-6 μL cell-free expressing EglS corresponded to 100-200 mU of the purified 
enzyme. Similarly 1-10 μL of XynA expressing LTE corresponds to 10-200 mU of 
the purified enzyme. The relatively small volume of enzyme expressing lysate 
required for the assay and the inexpensive substrate facilitated comprehensive 
characterization of xylanases and endo-1,4-β-glucanases in a higher throughput 
manner compared to previous systems. 
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Bioinformatic identification of xylanase and endo-1,4-β-glucanase candidates from 
genomic databases 
 
Having developed a pipeline suitable for high-throughput activity screening we 
wanted to identify from the available genomic data xylanase and endo-1,4-β-
glucanase proteins that would have an increased likelihood of displaying high 
thermostability. Using an in-house bioinformatics protocol we collected all publically 
available sequences annotated as encoding xylanases (1658 genes) or endo-1,4-β-
glucanases (4154 genes). We listed them together with the optimal growth 
temperatures of their hosts and their predicted thermostability score obtained by an in-
house scoring algorithm. This score was dependent on the number of prolines as well 
as on predicted surface charge and hydrophobicity of the core obtained by amino acid 
alignment of the putative enzymes with the available crystal structures of the related 
enzymes. Using these selection criteria we selected fifteen putative endo-1,4-β-
glucanases and twelve putative xylanases as well as three xylanases proven to exist on 
a protein level (Table 1). One of the putative xylanases (X10) is identified through 
metagenomic sequencing whereas the other putative xylanases and endo-1,4-β-
glucanases are identified by sequence homology from genomic data of cultured 
organisms. All of the selected xylanases showed sequence similarity to one 
characterized fold (β-Jelly roll) of the glycoside hydrolase family 11 (Lombard et al., 
2014). The identified endo-1,4-β-glucanases formed a structurally more 
heterogeneous group. They belong to six glycoside hydrolase families (5, 6, 8, 9, 35, 
44) and align to three characteristic folds: (β/α)8, (β/α)n or (α/α)6.  
The amino acid sequences of the candidate genes were aligned and the portions of the 
respective sequences, flanking the catalytic domain consensus, were removed (Table 
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S1). The sequences were commercially synthesized de novo and cloned into the pLTE 
vector (Gagoski, Mureev, et al., 2015). The selected enzymes were expressed in the 
LTE-based cell-free system in presence of BODYPI-Lysine-tRNA to facilitate 
visualization and quantification of expressed products (Figure 2). Expression levels 
differed 9-fold among the candidate endo-1,4-β-glucanases and an even greater 
difference (28-fold) was observed for xylanases, in spite of the more uniform size and 
fold. The variance may be attributed to overrepresentation of rare codons in individual 
sequences or secondary structures in the mRNA remaining despite sequence 
optimisation.  
 
Screening for pH-dependent activity of xylanase and endo-1,4- β-glucanase  
 
As feedstock additives are required to display high enzymatic activity in the acidic 
environment of the digestive tract of livestock, we performed a pH profiling of the 
constructed xylanase and endo-1,4-β-glucanase libraries (Figure 3). Of 15 selected 
endo-1,4-β-glucanases only five were active under the chosen conditions. This lack of 
activity may be a result of the absence of the catalytic domains’ flanking sequences, 
but also is likely to be a consequence of the structural heterogeneity across the 
enzyme class that led to erroneous identification and annotation and is indirectly 
supported by the observation that the structurally uniform xylanase library contained 
only three inactive candidates. One of these xylanases originates from a thermophilic 
organism and has been previously characterized to be active at temperatures above 50 
°C (Mäntylä et al., 2007). Despite the fact that the volume of the cell-free expressed 
enzyme was not adjusted to the expression levels, we observed no correlation between 
the expression levels and the activity. This lack of correlation indicates that there are 
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significant differences in the activity levels among selected enzymes. The enzymes 
also show different levels of activity at different pH values.  
All of the endo-1,4-β-glucanases and xylanases express as soluble proteins in the 
LTE-based cell-free expression system. However, for some of the investigated 
candidates there was visible precipitation in the activity assay reactions with low pH 
values. Although majority of this precipitation most likely consists of the LTE-protein 
(especially for the assay reactions where higher volume of cell-free protein expression 
reaction was added), it suggests that some of the endo-1,4-β-glucanases and xylanases 
exhibit no activity due to instability at low pH values or co-precipitation.     
 
Characterization of the endo-1,4-β-glucanase library 
 
Next, we pre-incubated five active endo-1,4-β-glucanases at different temperatures 
and analysed their activity at four different pH (Figure 4). The low variance in 
expression levels of the active candidates enabled us to adjust the volumes of the 
enzyme-expressing lysate to directly compare the activity of different proteins. The 
reaction plate was imaged after an overnight incubation at room temperature, which 
helped to reveal very low activities that became apparent only after long incubations. 
Two of the candidates exhibited significantly lower activity than the others; G02 is 
not thermostable and only active at neutral pH, while G15 is active enough so that the 
activity can be detected. However this low activity of G15 is observed at lower pH 
values after exposure at elevated temperatures (60 °C – 75 °C) as well as at neutral 
pH levels after exposure at high temperatures. This activity profile of G15 needs to be 
tested at a higher assay temperature than the one used for this investigation (40 °C), at 
which it can exhibit higher activity, as it comes from a thermophilic organism 
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(Spirochaeta thermophila, temperature growth range 40°C- 73°C) (Aksenova et al., 
1992). The G12 candidate is more active than the previous two, but neither 
thermostable nor acidophilic. Finally G03 and G04 both show higher activity than the 
EglS that was used as a standard. Although the G03 is the most active endo-1,4-β-
glucanase it does not tolerate exposure to temperatures above 60 °C, whereas the G04 
is stable up to 75 °C. At the lowest pH observed in the gastrointestinal tract of 
poultry, the gizzard pH 3.0-3.5 (Mabelebele et al., 2014), no activity was detected for 
any of the candidate enzymes. Although the screen did not yield an endo-1,4-β-
glucanase that could be used as animal feed supplement immediately, it uncovered 
five previously uncharacterized enzymes with favourable properties. The G15 endo-
1,4-β-glucanase showed the most favourable properties and is consequently a 
candidate for enzyme engineering. 
 
Characterization of the xylanase library  
 
We repeated the procedure described above for cell-free lysates expressing active 
xylanases and the control lysate expressing XynA. However, due to the larger 
variation in expression levels the reactions were not adjusted to the relative 
expression levels, as this would introduce pipetting errors. Consequently, we could 
only directly compare the activity for each candidate at different pH values and after 
exposure at different temperatures (Figure 5). A number of the xylanases (X01; 05; 
07; 08 and 10) remained active when exposed to temperatures of up to 70 °C. Further, 
the XynA as well as the X02 and X12 displayed detectable activity even after 
exposure to 95 °C. However, both groups are active only between pH 6.7 and 4.1. In 
contrast, X03, X04 and X15 were active at pH as low as 3.0. The X15 can be 
15 
 
classified as acidophilic xylanase due to its activity optimum between pH 5.2 and 3.0. 
This group of more acidophilic enzymes is however not stable at temperatures higher 
than 56-60 °C. Unlike X15, X11 is not active at pH 3.0, but can withstand heat 
treatment at 95 °C. Finally, the X14 xylanase is the only one exhibiting activity at pH 
3.0 after being heat-treated at 95 °C. Remarkably during the kinetic measurement, this 
xylanase exhibited activity after being exposed to 40, 50, 85.4 and 95 °C but only 
very low or undetectable activity at 56, 60, 70 and 75 °C. The reactions at these 
temperatures (56-75 °C) were identified as positive after a day of incubation at room 
temperature. These observations suggest that the X14 refolds into the active form 
after denaturation at 85-95 °C, but the exposure to 56-75 °C induced a different and 
inactive conformation. In addition, this xylanase is more active at pH 5.2-3.0, thus 
making it potentially suitable for use as a feed supplement. To get a better insight into 
how the activity levels compare among the xylanases the maximal slope of the 
reactions was divided by the relative expression levels (Figure S2). Relative to the 
XynA the xylanases X01, 03 and 10 show very low activity, whereas the X04, 05, 07, 
14 and 15 are two to fourfold more active. Finally, X02, 08, 11 and 12 are more than 
ten-fold more active than the XynA. Hence, all of the three most promising 
candidates, the thermostable X11, the acidophilic X15 and acidophilic re-folder X14 
show higher activity levels than the control xylanase when the relative expression 
levels are taken into account. This result demonstrates the suitability of the pipeline 
for discovery novel xylanases from a computationally selected library. 
 
Conclusions 
In this report we describe an integrated pipeline for discovery of novel xylanases and 
endo-1,4-β-glucanases. The developed enzymatic assay offers a real time 
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measurement of enzyme activity and produces semi-quantitative data in a multiplexed 
format. Furthermore, the stability of the labelled substrates used in this assays makes 
it amenable to investigation of the thermophilic and acidophilic properties of the 
enzymes. Since the Leishmania tarentolae-based cell-free protein expression system 
does not produce a significant background signal with the assay, its integration with 
the enzymatic assay builds the foundation for all in vitro pipeline for enzyme activity 
screening. We used this pipeline to discover and characterize xylanases and endo-1,4-
β-glucanases suitable for animal feed applications. Fifteen candidates for each 
enzyme were selected from the publically available sequences with an in-house 
algorithm used to enrich for thermostable enzymes (manuscript in preparation). Most 
of the candidate genes were putatively assigned as xylanases and endo-1,4-β-
glucanases and have not been biochemically characterized before. Furthermore, one 
of the xylanase candidates was identified from an uncultured organism through 
metagenomic sequening. In the pilot screen reported here we chose to synthesize and 
clone fifteen xylanases and endo-1,4-β-glucanases to showcase the screening pipeline. 
DNA synthesis eliminated the need for culturing of the source organisms and cloning 
the gene for each enzyme. Using the cell-free system for the expression of the 
enzymes and the continuous activity assay we were able to rapidly characterize both 
sets of enzymes. The preliminary activity screen showed that although all open 
reading frames were expressed, there was a clear difference in frequency of 
occurrence of active candidates between the two enzyme groups. This difference of 
5/15 active endo-1,4-β-glucanases to 12/15 active xylanases can be attributed to the 
structural diversity, reflected in the number of glycoside hydrolase families. Activity 
characterization of the endo-1,4-β-glucanases identified one thermostable candidate, 
whereas three xylanases out of fifteen displayed favourable activity profiles. One 
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xylanase was highly active and thermostable, another acidophilic and the third most 
interesting xylanase (X14) was both active at low pH and capable of refolding into an 
active conformation after exposure to high temperatures. These features make the last 
enzyme a promising candidate for further development towards application as a feed 
supplement. With the development of the enzymatic assay in combination with 
genomic database mining, commercial DNA synthesis and cell-free protein 
expression we have established a time- and cost-efficient pipeline for discovery of 
novel xylanases and endo-1,4-β-glucanases suited for specific applications such as 
feed supplements.  
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Figure captions: 
 
Figure 1: Characterisation of a semi-quantitative glucanase and xylanase assay with 
purified and cell-free expressed enzymes. Enzyme activity of commercial endo-1,4-β
-glucanase (A) and xylanase (B) measured as change in OD590 over time plotted 
against the substrate concentration. The titrations were performed using total reaction 
concentration of 1 U/mL of endo-1,4-β-glucanase and 5 U/mL of xylanase. Titration 
of purified and LTE expressed enzymes to the assay mixture containing fixed 
amounts of substrates. (C) Purified EglS endo-1,4-β-glucanase of known activity and 
EglS –expressing LTE lysate were titrated into 200 μL of the reaction volume 
containing 500 μg/mL AZCL HE-cellulose. (D) Purified XynA xylanase of known 
activity as well as XynA expressing LTE lysate were titrated into 400 μg/mL AZCL-
xylan. The ΔOD590/Δt were determined as the maximum slope of 20 consecutive 
measuring points from the kinetic read. Error bars represent the Standard Deviation. 
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Figure 2: SDS-PAGE analysis of endo-1,4-β-glucanases and xylanases expressed 
with LTE-based cell-free expression system. SDS-PAGE analysis of 10 μL endo-1,4-
β-glucanases and xylanases expressed in the presence of BODYPI-Lysine-tRNA in 
LTE cell-free system (A). (B) The expression levels for each enzyme were estimated 
by comparing the fluorescence band intensities to the one of 10 μL eGFP co-
expression with BODYPI-Lysine-tRNA in LTE-based cell-free system, after dividing 
the band intensities by their respective number of lysines. The expression level of 
LTE-based cell-free expressed eGFP in was derived by interpolating the western blot 
signal of 10 μL expression reaction to the signals of purified eGFP dilution series. 
This estimation was performed on the total expression reaction. 
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Figure 3: Activity screening of endo-1,4-β-glucanase (left) and xylanase (right) 
candidates at four pH values and 40 °C. The ΔmOD590/Δt values for all 
candidates were compared, where the highest slope is represented as 100% activity 
(red) and no change in OD590 is represented as 0% (blue). 
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Figure 4: Relative activity levels of candidate endo-1,4-β-glucanase at four pH 
values and after exposure at eight different temperatures. The highest recorded 
activity is taken as the maximal activity (100%, red) for all of the investigated endo-
1,4-β-glucanases. Reactions that did not produce a signal above the noise within the 
kinetic read (0%, blue), but resulted in increased OD590 after an overnight incubation 
at room temperature are designated with a red dot. These reactions need to be 
repeated with higher enzyme concentrations in order to be validated. The values are 
averages of triplicates. Relative to a commercial endo-1,4-β-glucanase the highest 
measured activity level (100%) is estimated to 9 ± 1 U. 
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Figure 5: Relative activity levels of xylanases at four pH values and after exposure to 
eight different temperatures. Due to the different expression levels of the enzymes the 
relative activities were compared for the different conditions for each enzyme. The 
highest recorded activity is taken as the maximal activity (100%, red) for the 
respective xylanase. Reactions that did not produce a signal above the noise within 
the kinetic read (0%, blue) but resulted in increased OD590 after an overnight 
incubation at room temperature are designated with a red dot. These reactions need to 
be repeated with higher enzyme concentrations in order to be validated. The 
compared values are averages of triplicates. Relative to a commercial xylanase the 
highest measured activity levels (100%) for the respective xylanases are estimated to: 
X00: 4.6 ± 0.5 U; X01: 0.1 ± 0.05 U; X02: 29.6 ± 6 U; X03: 0.8 ± 0.2 U; X04: 2 ± 0.3 
U; X05: 3.2 ±0.2 U; X07: 2.4 ± 0.2 U; X08: 3 ± 0.3 U; X10: 1.1 ± 0.2 U; X11: 34.1 ± 
2 U; X12: 27.9 ± 2 U; X14: 25.5 ± 2.5 U; X15: 5.3 ± 0.7 U. 
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Table captions: 
 
Table 1: List of endo-1,4-β-glucanases and xylanases used in this study. 
List of endo-1,4-β-glucanases and xylanases selected from the publicly available 
genomic database analysis. The list shows to which glycoside hydrolase family each 
candidate belongs and the most probable fold. Evidence for existence on a protein 
level was obtained from www.uniprot.org. 
 
Endo-1,4-β-glucanases  
Candidat
e 
Organism 
GH 
family 
Fold 
Evidence at protein 
level 
G00 
(eglS) 
Bacillus subtillis 5 ( β / α )8 yes 
G01 Medicago truncatula 9 ( α / α )6 no 
G02 Bacillus licheniformis 9 ( α / α )6 no 
G03 Clostridium cellulolyticum 9 ( α / α )6 no 
G04 Melioribacter roseus 9 ( α / α )6 no 
G05 
Streptomyces 
bingchenggensis 
6 ( β / α )n no 
G06 Eubacterium siraeum 35 ( β / α )8 no 
G07 Melissococcus plutonius 5 ( β / α )8 no 
G08 
Coprinopsis cinerea 
okayama 
5 ( β / α )8 no 
G09 
Streptomyces 
rapamycinicus 
6 ( β / α )n no 
G10 Brevundimonas sp. 5 ( β / α )8 no 
G11 Halosimplex carlsbadense 5 ( β / α )8 no 
G12 Paenibacillus polymyxa 44 ( β / α )8 no 
G13 
Streptomyces 
violaceusniger 
6 ( β / α )n no 
G14 Castellaniella defragrans 8 ( α / α )6 no 
G15 Spirochaeta thermophila 5 ( β / α )8 no 
Xylanases 
Cadidate Organism 
GH 
family 
Fold 
Evidence at protein 
level 
X00 
(XynA) 
Bacillus subtillis 11 
β-jelly 
roll 
yes 
X01 Penicillium oxalicum 11 
β-jelly 
roll 
no 
X02 Neocallimastix frontalis 11 
β-jelly 
roll 
no 
X03 Thielavia terrestris 11 
β-jelly 
roll 
no 
X04 Ustilago maydis 11 
β-jelly 
roll 
yes 
X05 Humicola insolens 11 
β-jelly 
roll 
no 
X06 Cellulophaga algicola 11 β-jelly no 
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roll 
X07 Setosphaeria turcica 11 
β-jelly 
roll 
no 
X08 Fusarium verticillioides 11 
β-jelly 
roll 
no 
X09 Ruminococcus flavefaciens 11 
β-jelly 
roll 
no 
X10 Enviromental Bacteria 11 
β-jelly 
roll 
no 
X11 Ruminococcus albus 11 
β-jelly 
roll 
no 
X12 Neocallimastix frontalis 11 
β-jelly 
roll 
no 
X13 Chaetomium thermophilum 11 
β-jelly 
roll 
yes 
X14 Talaromyces stipitatus 11 
β-jelly 
roll 
no 
X15 Bispora sp. 11 
β-jelly 
roll 
yes 
 
 
